Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Clinical trial NCT00134953 · TERMINATED

Trial details

NCT number: NCT00134953
Sponsor: Novartis
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cognitive Symptoms

Start date: 2003-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.